163
Participants
Start Date
September 5, 2019
Primary Completion Date
October 31, 2022
Study Completion Date
October 31, 2024
Durvalumab
IV infusion q4w with 1500mg durvalumab until progressive disease
Research Site, Tainan City
Research Site, Lausanne
Research Site, Brussels
Research Site, Budapest
Research Site, Dresden
Research Site, Sofia
Research Site, Melbourne
Research Site, Leuven
Research Site, Box Hill
Research Site, Miskolc
Research Site, Kyiv
Research Site, Kortrijk
Research Site, Bangkok
Research Site, Taipei
Research Site, Mineola
Research Site, Seongnam-si
Research Site, Girona
Research Site, Washington D.C.
Research Site, Vinnytsia
Research Site, Baltimore
Research Site, Kamenitz
Research Site, Jaén
Research Site, New Taipei City
Research Site, Kirovohrad
Research Site, Chapel Hill
Research Site, Madrid
Research Site, Madrid
Research Site, Huntersville
Research Site, Málaga
Research Site, Marbella
Research Site, Greenville
Research Site, Brest
Research Site, Hanover
Research Site, Augusta
Research Site, Istanbul
Research Site, Nashville
Research Site, Sumy
Research Site, Taichung
Research Site, Taichung
Research Site, Daegu
Research Site, Valencia
Research Site, Seogu
Research Site, Kryvyi Rih
Research Site, Gyeongsangnam-do
Research Site, Minneapolis
Research Site, Chernivtsі
Research Site, Lille
Research Site, Kharkiv
Research Site, Gwangju
Research Site, St Louis
Research Site, Lyon
Research Site, Dallas
Research Site, Ivano-Frankivsk
Research Site, Uzhhorod
Research Site, Songkhla
Research Site, Haifa
Research Site, Fullerton
Research Site, Kuching
Research Site, Hanoi
Research Site, Moscow
Research Site, Moscow
Research Site, Arkhangelsk
Research Site, Saint Petersburg
Research Site, pos.Pesochnyi
Research Site, Saint Petersburg
Research Site, Craiova
Research Site, Chennai
Research Site, Omsk
Research Site, Suceava
Research Site, Santiago
Research Site, Rosario
Research Site, Florianópolis
Research Site, Ijuí
Research Site, Porto Alegre
Research Site, São José do Rio Preto
Research Site, Calgary
Research Site, Toronto
Research Site, Greater Sudbury
Research Site, Newmarket
Research Site, Olomouc
Research Site, Holargos, Athens
Research Site, Bunkyō City
Research Site, Fukushima
Research Site, Isehara-shi
Research Site, Izumi-shi
Research Site, Kishiwada-shi
Research Site, Kōtoku
Research Site, Nagaoka-shi
Research Site, Nagoya
Research Site, Natori-shi
Research Site, Okayama
Research Site, Osaka
Research Site, Saga
Research Site, Suita-shi
Research Site, Sunto-gun
Research Site, Tokushima
Research Site, Yokohama
Research Site, Amsterdam
Research Site, Arnhem
Research Site, Lodz
Research Site, Lodz
Research Site, Olsztyn
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Badalona
Research Site, Barcelona
Research Site, Barcelona
Research Site, Barcelona
Research Site, Bellinzona
Research Site, Adana
Research Site, Kyiv
Research Site, Kyiv
Research Site, London
Research Site, London
Research Site, Manchester
Lead Sponsor
Collaborators (2)
Iqvia Pty Ltd
INDUSTRY
Parexel
INDUSTRY
Medidata Solutions
INDUSTRY
CISCRP
INDUSTRY
AstraZeneca
INDUSTRY